Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum

被引:48
作者
Gangneux, JP [1 ]
Dullin, M [1 ]
Sulahian, A [1 ]
Garin, YJF [1 ]
Derouin, F [1 ]
机构
[1] Fac Med Lariboisiere St Louis, Lab Parasitol Mycol, F-75270 Paris 06, France
关键词
D O I
10.1128/AAC.43.1.172
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In a murine model of Leishmania infantum visceral leishmaniasis, metronidazole, ketoconazole, fluconazole, itraconazole, and terbinafine were less effective than antimonial agents in reducing hepatic parasite load. Ketoconazole potentiated the effect of meglumine antimoniate reference therapy through its marked activity against spleen infection.
引用
收藏
页码:172 / 174
页数:3
相关论文
共 31 条
[1]   Leishmania and human immunodeficiency virus coinfection: The first 10 years [J].
Alvar, J ;
Canavate, C ;
GutierrezSolar, B ;
Jimenez, M ;
Laguna, F ;
LopezVelez, R ;
Molina, R ;
Moreno, J .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :298-+
[2]   METRONIDAZOLE TREATMENT IN A PATIENT WITH AIDS AND VISCERAL LEISHMANIASIS [J].
ARRANZCASO, JA ;
ALBARRANHERNANDEZ, F ;
CUADRADOGOMEZ, LM ;
GONZALEZPALACIOS, R .
AIDS, 1995, 9 (12) :1377-1378
[3]   VISCERAL LEISHMANIASIS IN THE BALB/C MOUSE - SODIUM STIBOGLUCONATE TREATMENT DURING ACUTE AND CHRONIC STAGES OF INFECTION [J].
BAILLIE, AJ ;
DOLAN, TF ;
ALEXANDER, J ;
CARTER, KC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 57 (01) :23-28
[4]   SUCCESSFUL TREATMENT OF CUTANEOUS LEISHMANIASIS WITH ALLOPURINOL AFTER FAILURE OF TREATMENT WITH KETOCONAZOLE [J].
BAUM, KF ;
BERENS, RL .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (05) :813-815
[5]   Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years [J].
Berman, JD .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :684-703
[6]   CULTURE MICROTITRATION - A SENSITIVE METHOD FOR QUANTIFYING LEISHMANIA-INFANTUM IN TISSUES OF INFECTED MICE [J].
BUFFET, PA ;
SULAHIAN, A ;
GARIN, YJF ;
NASSAR, N ;
DEROUIN, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) :2167-2168
[7]   VISCERAL LEISHMANIASIS - DRUG CARRIER SYSTEM CHARACTERISTICS AND THE ABILITY TO CLEAR PARASITES FROM THE LIVER, SPLEEN AND BONE-MARROW IN LEISHMANIA-DONOVANI INFECTED BALB/C MICE [J].
CARTER, KC ;
DOLAN, TF ;
ALEXANDER, J ;
BAILLIE, AJ ;
MCCOLGAN, C .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (02) :87-91
[8]   VISCERAL LEISHMANIASIS IN THE BALB/C MOUSE - ANTIMONY TISSUE DISPOSITION AND PARASITE SUPPRESSION AFTER THE ADMINISTRATION OF FREE STIBOGLUCONATE [J].
COLLINS, M ;
CARTER, KC ;
BAILLIE, AJ .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1992, 86 (01) :35-40
[9]   LEISHMANIASIS - SOME RECENT DEVELOPMENTS IN CHEMOTHERAPY [J].
COOK, GC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (03) :327-330
[10]  
DAN M, 1986, CUTIS, V38, P198